How Are Global Trends in Rheumatoid Arthritis Evolving?
Rheumatoid arthritis (RA) disease burden increased globally from 1980 to 2021, with significant disparities. Local administrative units in the UK and Mexico had the highest rates of incidence and disability-adjusted life years (DALYs), respectively, in 2021.
METHODOLOGY:
Researchers analyzed RA data from the largest spatiotemporal dataset — the Global Burden of Disease 2021 report — covering 953 global to local locations from 1980 to 2021.
They sourced data on incidence, prevalence, mortality, DALYs, years of life lost, and years lived with disability and applied spatiotemporal smoothing methods to address data gaps.
The modified iTransformer model, a deep learning algorithm, used data from a 13-year historical period (1990-2002) to fit and forecast outcomes over the following 19 years (2003-2021). Long-term burdens were forecasted until 2040 using the current trend as a reference.
TAKEAWAY:
The global burden of RA increased, with a 13.2% increase in age-standardized incidence from 1990 to 2021. Western Europe and North America had higher incidence, and local administrative units in the UK and Mexico showed the highest age-standardized incidence and DALY rates, respectively.
RA incidence was highest globally among individuals older than 55 years, but after 2015, trends shifted toward younger age groups, particularly in areas with a high sociodemographic index. Despite its high sociodemographic index, Japan showed declining DALY rates, whereas DALY rates increased in the UK.
The age-standardized death rate for RA decreased by 32.7% from 1980 to 2021, whereas DALY rates increased twofold, with individuals older than 55 years having the highest rates.
Between 1990 and 2021, most countries and regions drifted further away from the ideal disease burden line for both incidence and DALY rates. Population growth, aging, and changes in epidemiology have all led to a rise in the incidence and prevalence of RA worldwide, with aging and population growth influencing variably at the national level.
Forecasts indicate that by 2040, regions with a high medium-to-low sociodemographic index may see increasing age-standardized DALY rates, whereas areas with a high sociodemographic index may experience a decrease.
IN PRACTICE:
'[The study] provides robust evidence for global to local policymakers and stakeholders to formulate interventions and allocate resources effectively, mitigating RA impacts for their populations,' the study authors wrote.
SOURCE:
This study was led by Wenyi Jin of Renmin Hospital of Wuhan University, Wuhan; Qian Wang of Peking Union Medical College Hospital, Beijing; and Cheng Jin of Shenzhen Children's Hospital, Shenzhen, all in China. It was published online on June 16, 2025, in Annals of the Rheumatic Diseases .
LIMITATIONS:
Data quality limitations, along with possible underdiagnosis and underreporting in resource-limited areas, may have led to an underestimated burden of RA. Data were available only from 1990 onward for certain countries and excluded individuals younger than 20 years because of insufficient data on risk factors. The analysis did not consider heterogeneity in healthcare infrastructure, which could introduce confounding effects.
DISCLOSURES:
This study was supported by the World Health Organization and the Bill & Melinda Gates Foundation. The authors declared having no conflicts of interest.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Oxford University beaten to top spot in new 2026 ranking
The University of Oxford has missed out on the top spot in a new 2026 ranking. Released this week, the 2026 Complete University Guide rankings have been released which feature the prestigious institution heavily. These rankings offer a detailed look at how every UK university stacks up against key measures like student satisfaction, graduate prospects, research quality and more. The annual rankings are widely followed by students, parents and educators and include a breakdown of each set of subjects. READ MORE: David Beckham wins neighbour battle over £6m Cotswolds estate plans Cambridge claimed top spot in the new university rankings. Oxford has been beaten by bitter rival Cambridge in the overall ranking, finishing in second place. Following the Oxbridge institutions are the London School of Economics and Political Science, the University of St Andrews and Durham University. Imperial College London, Loughborough University and the University of Bath all follow in the new ranking. The University of Warwick and Lancaster University round off the top 10 while the Universities of Exeter and York rank just Mail readers can subscribe for just £4 for 4 months in this flash sale — Oxford Mail (@TheOxfordMail) June 10, 2025 Oxford has been ranked top of the Times Higher Education World University Rankings for nine consecutive years. The prestigious institution was recently named the best in the world for three subjects in international rankings. QS World University Rankings 2025 saw the prestigious institution claim the top spot for English Language and Literature, Anatomy and Physiology, and Geography. In the new 2026 Complete University Guide rankings, Oxford was ranked best in the UK in 10 subjects.
Yahoo
an hour ago
- Yahoo
'Forever chemical' found in dozens of UK rivers, study finds
A "forever chemical" that scientists worry might have an impact on reproduction has been found in all but one of 32 rivers tested across the UK, according to a study. Researchers say trifluoroacetic acid (TFA), which can take hundreds of years to break down, was detected at 98% of the 54 sites they investigated. According to the study, one sample - taken from the River Kelvin in Glasgow - contained the second-highest value of TFA ever recorded in surface water globally. The researchers say the average concentrations of TFA in the UK are at the "higher end" of the global scale compared with the results obtained from other studies - and that the chemical has been found in 31 of the 32 rivers analysed. The research - funded by environmental charity Fidra and carried out by the University of York - looked at how much TFA was present in surface water. It marks the first time such a project has been carried out in the UK. TFA is a type of per- and polyfluoroalkyl substance (PFAS) - also known as "forever chemicals" - found in pesticides, pharmaceuticals and fluorinated gases (F-gases). But there is "growing concern" about the general impact on human health and its potential risks to drinking water supplies. According to Fidra, TFA is thought to have "low to moderate" toxicity; however, because levels are rapidly rising in the environment, there are concerns about future impacts. Studies have linked TFA exposure to birth defects in rabbits, while similar short-chained PFAS have been shown to have toxic effects on freshwater organisms. The German Federal Environment Agency (UBA) has applied to the European Chemicals Agency (ECHA) for TFA to be classified as toxic for reproduction. However, its impacts are still being researched. 'Increasingly concerned' Experts say the results of the latest study provide "compelling evidence of the presence of TFA and PFAS in UK waterways". The researchers added: "These data should be further analysed to try and establish the drivers of TFA contamination in UK surface waters and routes for source control should be prioritised. "The scientific communities are becoming increasingly concerned about the potentially harmful properties of TFA and increasing levels in the environment, particularly in water sources. "There are currently no practical or economically viable ways to remove TFA from water supplies. "TFA was found in 31 of the 32 rivers examined." Read more from Sky News: Samples were taken from sites across northern England, Wales, Scotland, and Northern Ireland. Scientists say TFA has the potential to cause reproductive and liver issues in mammals and is harmful to aquatic life. It also accumulates in crops and fields and "builds up" in drinking water. The research comes as a committee of MPs said the UK's water sector is in need of "root-and-branch reform". The cross-party Environment, Food and Rural Affairs (DEFRA) committee said the industry is "failing" - and trust and accountability in the sector was "very low".
Medscape
2 hours ago
- Medscape
DASH4D Diet for BP Control in T2D: Less Salt, Better Results
In adults with type 2 diabetes (T2D) on multiple antihypertensive medications, a modified Dietary Approaches to Stop Hypertension for Diabetes (DASH4D) diet combined with reduced sodium intake led to a clinically relevant reduction in systolic blood pressure (BP), with the benefits primarily attributed to sodium reduction. METHODOLOGY: Although the original DASH diet — rich in fruits, vegetables, and low-fat dairy products and low in saturated fat and cholesterol — is recommended with sodium reduction for managing hypertension in patients with T2D, evidence of its effectiveness in this population remains limited. Researchers conducted a single-site study in Maryland to assess the efficacy of the DASH4D diet, featuring lower carbohydrates, higher unsaturated fats, and lower potassium than the original DASH diet, together with reduced dietary sodium for BP management in T2D. They included 102 adults with T2D (mean age, 66 years; 66% women) between June 2021 and December 2023; the patients had a mean baseline BP of 135/75 mm Hg; 66% of them used at least two antihypertensive medicines, and 55% used two or more glucose-lowering medicines. Participants were randomly assigned to be provided with four diets in sequence, each for 5 weeks: The DASH4D diet with lower sodium, DASH4D diet with higher sodium, typical US diet with lower sodium, and typical US diet with higher sodium; in a 2000-kcal menu, the lower and higher sodium levels were set at 1500 mg/d and 3700 mg/d, respectively. The primary outcome was end-of-period systolic BP, measured on 5 separate days during the last 2 weeks of each feeding period. TAKEAWAY: Compared with patients on the typical US diet with higher sodium, those who received the DASH4D diet with lower sodium showed an average systolic BP reduction of 4.6 mm Hg (95% CI, -7.2 to -2.0) and an average diastolic BP reduction of 2.3 mm Hg (95% CI, -3.7 to -0.9) after 5 weeks. Among patients on the DASH4D diet, systolic BP was reduced by 4.8 mm Hg (95% CI, -7.4 to -2.2) in those with lower vs higher dietary sodium. Most reductions in BP occurred during the first 3 weeks of each diet period. Patients completely adhered to the recommended diet for 96% of the study days. The frequency of adverse events was low. IN PRACTICE: '[The findings] provide evidence of the efficacy of BP lowering through dietary change in people with T2D, including those treated with multiple antihypertensive and glucose-lowering medications,' the authors of the study wrote. 'High adherence to the DASH4D lower sodium diet suggests that the diet is acceptable.' SOURCE: This study was led by Scott J. Pilla, MD, MHS, Johns Hopkins University School of Medicine in Baltimore. It was published online on June 9, 2025, in JAMA Internal Medicine . LIMITATIONS: This study was not powered sufficiently to detect individual effects of the DASH4D diet and sodium reduction. As a single-center study, the study population lacked diversity. Participant feeding was disrupted at multiple points owing to the COVID-19 pandemic. DISCLOSURES: This study received funding from the Sheikh Khalifa Stroke Institute at Johns Hopkins University School of Medicine, grants from National Institute of Diabetes and Digestive and Kidney Diseases, National Heart, Lung, and Blood Institute grant, and the National Center for Advancing Translational Science Awards Program. Several authors reported receiving grants from sources including the funding agency and National Institutes of Health. Some authors reported serving on the scientific advisory board or receiving personal fees outside the submitted work.
